Skip to Main Content

Paper Details

HER2 Low, Ultra-low, and Novel Complementary Biomarkers: Expanding the Spectrum of HER2 Positivity in Breast Cancer.
Front Mol Biosci
50
2022
Author NameAffiliation
Chiara CortiUniversity of Milan
Chiara CortiEuropean Institute of Oncology, IRCCS
Giuseppe CuriglianoUniversity of Milan
Giuseppe CuriglianoEuropean Institute of Oncology, IRCCS
Carmen CriscitielloUniversity of Milan
Carmen CriscitielloEuropean Institute of Oncology, IRCCS
Nicola FuscoEuropean Institute of Oncology IRCCS
Nicola FuscoUniversity of Milan
  • 1 - 8

Datasets

Release 1.2